semaglutide clearance Levels of circulating determine reductions in HbA1c and body weight in people with type 2 diabetes: Cell Reports Medicine Maximizing Semaglutide: Understanding the Doses

There is a possibility that weight lost with this treatment can be regained if the treatment is ceased

STEP-UP, a 72-week clinical trial carried out to study the weight loss effects of semaglutide (Wegovy), found that people lost an average 21% of their body weight after taking the 7.2mg maintenance dose

Potential dangers of Wegovy for the long haul include gallbladder issues, an inflamed pancreas pancreatitis and blocked intestines bowel obstruction among other risks

The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: Evidence from a network meta-analysis